Statement Of Cash Flows [Abstract]

GenSight Biologics S.A. - Filing #855040

Concept 2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for finance income (cost)
120,000 EUR
858,000 EUR
Cash flows from (used in) operations before changes in working capital
29,837,000 EUR
21,981,000 EUR
Increase (decrease) in working capital
3,916,000 EUR
4,841,000 EUR
Adjustments for increase (decrease) in other liabilities
3,240,000 EUR
4,428,000 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from sale or issue of treasury shares
305,000 EUR
Proceeds from exercise of warrants
37,000 EUR
439,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.